Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis

The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...

Descripción completa

Detalles Bibliográficos
Autores principales: Motl, Robert W, Cohen, Jeffrey A, Benedict, Ralph, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Invited Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405807/
https://www.ncbi.nlm.nih.gov/pubmed/28206828
http://dx.doi.org/10.1177/1352458517690823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405807/
https://www.ncbi.nlm.nih.gov/pubmed/28206828
http://dx.doi.org/10.1177/1352458517690823

Ejemplares similares